Ken Ren Net Worth & Insider Trades

Ken Ren - CEO and Director, Casi Pharmaceuticals, Inc

As of January 21, 2016

What is Ken Ren's Net Worth?

The current estimated net worth of Casi Pharmaceuticals, Inc's CEO and Director, Ken Ren, is estimated to be about $4.62M . Ken Ren owns about 15,000 units of Casi Pharmaceuticals, Inc common stock. Recently at Casi Pharmaceuticals, Inc, Ken Ren has sold an estimated value of $0 worth.

What is Ken Ren's Past Insider Trading?

Ken Ren's largest purchase order was 15,000 units , worth over $10.89K on January 21, 2016. In total, Ken Ren has made about 1 transaction recently at Casi Pharmaceuticals, Inc. Ken Ren usually trades in January, with the busiest year in 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Ken Ren's' Mailing Address?

  • Mailing address is 3rd Fl, Borough A, Block A No. 181 South Taibai Road Xi'An, Shaanxi Province F4 710065 China

Casi Pharmaceuticals, Inc Executive Compensation

Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Wei-Wu He, Ph.D. 2020 $577,656 - - - - $241,831 $819,487
Wei-Wu He, Ph.D. 2019 $423,848 - - $8,600,000 - $241,555 $9,265,103
Wei (Larry) Zhang 2020 $437,094 - - - - $278,675 $715,769
Wei (Larry) Zhang 2019 $339,207 - - $450,000 - $166,889 $985,186
Alexander Zukiwski, MD 2020 $414,529 - - - - $28,250 $442,779
Alexander Zukiwski, MD 2019 $407,600 $100,000 - $426,000 - $27,750 $961,350
Weihao Xu 2020 $14,583 - - $1,440,000 - - $1,454,583
No matching records found


What are Casi Pharmaceuticals, Inc's Past Insider Trades?

Casi Pharmaceuticals, Inc's most recent insider trade came on September 8, 2022 by James Huang who bought 55,573 units worth $229.66K . In the last 6 years, insiders at Casi Pharmaceuticals, Inc have sold an estimated value of $5.53M and bought an estimated value of $56.36M worth of shares. Insider trading is most common in June, with the busiest year in 2016. The most active traders at the company are Wei-Wu He, Chairman and CEO,  James Huang, Director,  and Cynthia W Hu, COO .

CASI Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found